MESA LABORATORIES INC /CO/ 8-KCurrent Reports (8-K / ad hoc)

Market for Equity / Stockholders

ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS On September 8, 2026, the Company held its annual meeting of shareholders (the “Annual Meeting”). Holders of 5,595,869 shares of Mesa’s common stock were entitled to vote, of which 4,872,692 shares were represented in person or by proxy at the Annual Meeting. The certified results of the matters voted upon at the Annual Meeting, which are more fully described in the Company’s proxy statement for the Annual Meeting, are as follows: Proposal 1 – Election of directors Each of John Sullivan, Siddhartha Kadia, Shiraz Ladiwala, Jennifer “Jenny” Alltoft, Mark Capone, Shannon Hall, and R. Tony Tripeny was elected to the Board of Directors of Mesa to hold office for a one-year term, until the 2027 annual meeting of shareholders: ​ ​ For ​ ​ Withheld ​ ​ Broker Non-Votes ​ John Sullivan, Ph.D. ​ ​ 4,388,976 ​ ​ ​ 145,521 ​ ​ ​ 338,195 ​ Siddhartha Kadia, Ph.D. ​ ​ 4,421,045 ​ ​ ​ 113,452 ​ ​ ​ 338,195 ​ Shiraz Ladiwala ​ ​ 4,402,912 ​ ​ ​ 131,585 ​ ​ ​ 338,195 ​ Jenny Alltoft ​ ​ 4,395,928 ​ ​ ​ 138,569 ​ ​ ​ 338,195 ​ Mark Capone ​ ​ 4,405,110 ​ ​ ​ 129,387 ​ ​ ​ 338,195 ​ Shannon Hall ​ ​ 4,399,078 ​ ​ ​ 135,419 ​ ​ ​ 338,195 ​ R. Tony Tripeny ​ ​ 4,352,734 ​ ​ ​ 181,763 ​ ​ ​ 338,195 ​ Proposal 2 – Ratification of the selection by our Audit Committee of Baker Tilly US, LLP to serve as the Company ’ s independent registered public accounting firm for the fiscal year ending March 31, 2027 The appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2027 was approved: For Against Abstain Broker Non-Votes 4,814,383 56,778 1,531 - Proposal 3 – Approval on a non-binding basis of the compensation of the Company's named executive officers The compensation of the Company’s named executive officers, as disclosed in the proxy statement, was approved on a non-binding advisory basis: For Against Abstain Broker Non-Votes 4,317,389 136,782 80,326 338,195 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DATE: September 8, 2026 Mesa Laboratories, Inc. (Registrant) BY: /s/ John Sakys John Sakys Chief Financial Officer